medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2020, Number 2

<< Back Next >>

Rev Med UAS 2020; 10 (2)

Clinical-epidemiological characteristics of COVID-19 patients in a Hospital of Sinaloa, México

Villagrán-Olivas KA, Torrontegui-Zazueta LA, Entzana-Galindo A

Language: Spanish
References: 24
Page: 65-79
PDF size: 882.61 Kb.


ABSTRACT

Objective: to describe the main clinical and epidemiological characteristics at diagnosis of patients with SARS CoV2 infection, detected at Civil Hospital of Culiacan during the period of March 2020 to May 2020. Study design: Observational, retrospective, crosssectional, descriptive study. Results: Out of 192 confirmed patients, more than 50% were between 40 and 65 years, healthcare personnel represented 16.67%. The most frequent clinical data at diagnosis was fever (84.4%), cough (83.8%), headache (74.8%) and dyspnea (65.1%). Obesity was found on 33.3%, Hypertension on 31.7% and Diabetes mellitus 21.9%. General mortality was 31.25%, 75% of them were intubated. 56.6% of deceases occurred on patients older than 60 years. Conclusions The observation of clinical-epidemiological characteristics of patients endorse the use of clinical approach at diagnosis and prognosis. Epidemiological surveillance is important, it should always lead to prevention and opportune actions.


REFERENCES

  1. Yi Y, Lagniton P, Ye S, Li E Xu RH. COVID-19:what has been learned and to be learnedabout the novel coronavirus disease. Int. J.Biol. Sci 2020; 16(10):1753–1766.

  2. Kamps BS, Hoffman C. COVID Reference.Cronología. Steinhäuser Verlag; 2020. p. 13-28.

  3. COVID-19 Tablero México [Base de datos eninternet]. México: Dirección General de Epidemiología.[Citado 22 de mayo de 2020]. Disponibleen: https://coronavirus.gob.mx/datos/

  4. Coronavirus Disease (COVID-19) SituationReport - 132 [Base datos en internet]. OrganizaciónMundial de la Salud. [Citado 09 de juniode 2020]. Disponible en:https://www.who.int/docs/default-source/coronaviruse/situation-reports/

  5. Gold JAW, Wong KK, Szablewski CM, PatelPR, Rossow J, da Silva J, et al. Characteristicsand Clinical Outcomes of Adult Patients Hospitalizedwith COVID-19 - Georgia, March2020. MMWR Morb Mortal Wkly Rep.2020;69(18):545–50.

  6. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiologicaland clinical features of theemerging 2019 novel coronavirus pneumonia(COVID-19) implicate special controlmeasures. J Med Virol. 2020;92(6):568–76.

  7. Garg S, Kim L, Whitaker M, O’Halloran A,Cummings C, Holstein R, et al. HospitalizationRates and Characteristics of Patients Hospitalizedwith. MMWR Morb Mortal Wkly Rep.2020;69(15):458–64.

  8. Adhikari SP, Meng S, Wu Y, Mao Y, Ye R,Wang Q, et al. Novel Coronavirus during theearly outbreak period: Epidemiology, causes,clinical manifestation and diagnosis, preventionand control. Infect Dis Poverty [Internet].2020;9(29):1–12. Disponible en:https://link.springer.com/article/10.1186/s40249-020-00646-x

  9. Richardson S, Hirsch JS, Narasimhan M, et al.Presenting Characteristics, Comorbidities, andOutcomes Among 5700 Patients HospitalizedWith COVID-19 in the New York City Area.JAMA. 2020;323(20):2052–2059.

  10. Docherty AB, Harrison EM, Green CA, HardwickHE, Pius R, Norman L, et al. Features of20 133 UK patients in hospital with covid-19using the ISARIC WHO Clinical CharacterisationProtocol: prospective observational cohortstudy. BMJ. 2020 May 22;2(March):m1985.

  11. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y,et al. Clinical features of patients infected with2019 novel coronavirus in Wuhan, China. Lancet.2020;395(10223):497–506.

  12. INEGI. México en Cifras [Internet]. 2020 [citado01 de Junio 2020]. Disponible en:https://www.inegi.org.mx/app/areasgeograficas/?ag=00

  13. INEGI. Anuario estadístico y geográfico de Sinaloa[Internet] 2017 [citado 01 de Junio2020]. Disponible en: http://internet.contenidos.inegi.org.mx/contenidos/Productos/prod_serv/contenidos/espanol/bvinegi/productos/nueva_estruc/anuarios_2017/702825094898.pdf

  14. Rojas-Martínez R, Basto-Abreu A, Aguilar-SalinasCA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de diabetespor diagnóstico médico previo en México. SaludPubl Mex. 2018 May 4;60(3, may-jun):224.

  15. Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S. Hipertensiónarterial en adultos mexicanos: prevalencia,diagnóstico y tipo de tratamiento. EnsanutMC 2016. Salud Publica Mex. 2018 May4;60(3, may-jun):233.

  16. Barquera S, Campos-Nonato I, Hernández-Barrera L. Prevalencia de obesidad en adultosmexicanos, ENSANUT 2012. Salud PublicaMex. 2013 Mar 5;55(Supl.2):151.

  17. Fang L, Karakiulakis G, Roth M. Are patientswith hypertension and diabetes mellitus at increasedrisk for COVID-19 infection LancetRespir Med. 2020;8(4):e21.

  18. Day M. Covid-19: identifying and isolatingasymptomatic people helped eliminate virus inItalian village. BMJ. 2020 Mar23;368(Marzo):m1165.

  19. Moriarty LF, Plucinski MM, Marston BJ, KurbatovaEV, Knust B, Murray EL, et al. PublicHealth Responses to COVID-19 Outbreaks onCruise Ships — Worldwide, February–March

  20. 2020. MMWR Morb Mortal Wkly Rep.2020;69(12):347–52.20. CDC COVID-19 Response Team. Characteristicsof Health Care Personnel with COVID-19—. MMWR Morb Mortal Wkly Rep.2020;69(15):477–81.

  21. Dirección General de Epidemiología. Lineamientoestandarizado para la vigilancia epidemiológicay por laboratorios de COVID-19.Secr Salud del Gob México [Internet]. 2020;1–58. Disponible en:https://www.gob.mx/cms/uploads/attachment/file/537944/Lineamiento_COVID-19_2020.02.27.pdf

  22. Secretaría de Salud. Proceso de Prevenciónde Infecciones para las personas con Covid-19 ( enfermedad por SARS- CoV-2 ), contactosy personal de la salud . Comisión Coordinadorade Institutos Nacionales de Salud yHospitales de Alta Especialidad 2020 p. 1–29.

  23. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S,Schünemann HJ, et al. Physical distancing,face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2and COVID-19: a systematic review and metaanalysis.Lancet. 2020;6736(20):1–15.

  24. European Centre for Disease Prevention andControl . Infection prevention and control forCOVID-19 in healthcare settings – Third update.2020. ECDC: Estocolmo; 2020.




2020     |     www.medigraphic.com